CHEMFABBSEChemfab Alkalis LtdHighNeutral
Announced Wed, 13 May · 22:12 IST

The Board Meeting held today i.e 13th May 2026, The Board has approved the recommendation of dividend of Rs. 1.25/- per equity share to the shareholders.

Revenue DeclinePat NegativeExceptional ItemResults View source PDF

CHEMFAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.8%1-day move
₹436.00
prior close
₹426.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.4+0.9+0.8-0.6-2.8-2.5-6.0-6.9-5.0-5.3-3.7-12.8-14.0
Up moveDown movePending
AI summary

Chemfab Alkalis reported FY2026 standalone revenue of Rs. 2,885.66 crore, down 10.4% from Rs. 3,220.91 crore in FY2025. Net profit fell sharply to Rs. 75.06 crore from Rs. 152.24 crore in the prior year (approximately 51% decline). Consolidated results show a net loss of Rs. 34.27 crore after accounting for exceptional items of Rs. 98.88 lakh. The Board recommended a final dividend of Rs. 1.25 per share (12.5% on Rs. 10 face value), subject to shareholder approval. New internal auditors (Brahmayya & Co) were appointed and cost auditors (Madhavan, Mohan & Associates) reappointed for FY2027. Statutory auditors Deloitte Haskins & Sells LLP issued an unmodified opinion on the financial statements.

Likely market impact

The company experienced significant profit erosion with standalone PAT declining over 50% and consolidated operations turning loss-making. While dividend payment signals management confidence, the weak financial performance and revenue decline may concern investors. The stock is listed on BSE (541269) and NSE (CHEMFAB).